lncRNA在动脉粥样硬化病变中的作用研究进展
李丽娟1 王庆高2 何亚州1 梁珊1 黄彩依1
1.广西中医药大学研究生院,广西南宁 530001;
2.广西中医药大学第一附属医院心血管内科,广西南宁 530001
Research progress on the effect of lncRNA in atherosclerosis lesions
LI Lijuan1 WANG Qinggao2 HE Yazhou1 LIANG Shan1 HUANG Caiyi1
1.Graduate School, Guangxi University of Chinese Medicine, Guangxi Zhuang Autonomous Region, Nanning 530001, China;
2.Department of Cardiovascular Medicine, the First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi Zhuang Autonomous Region, Nanning 530001, China
摘要 动脉粥样硬化(AS)引发的心脑血管疾病是造成死亡的主要原因之一,而AS是多因素、多机制协同作用的结果,内皮细胞功能障碍、血管平滑肌细胞增殖迁移、脂质代谢紊乱、炎性反应、细胞自噬等参与其中。因AS发病的复杂性,仍需从不同的角度完善对其发病机制的认识。近年来长链非编码RNA(lncRNA)被发现也参与基因的表达调控,作为肿瘤的生物标志物和治疗靶点已被广泛研究和应用,但在AS的研究尚处初始阶段。本文综述了lncRNA参与AS主要病变过程中的研究进展,以期为防治AS提供新思路。
关键词 :
动脉粥样硬化 ,
长链非编码RNA ,
病变 ,
研究进展
Abstract :The cardiovascular and cerebrovascular diseases caused by atherosclerosis (AS) is one of the main causes of death. AS is the result of synergistic effect of multiple factors and multiple mechanisms. The endothelial dysfunction, proliferation and migration of vascular smooth muscle cell, lipid metabolism disorders, inflammatory response and autophagy are involved in AS. Because of the complexity of its pathogenesis, it still needs to improve the understanding of its pathogenesis from different perspectives. In recent years, long non-coding RNA is found involving in regulating gene expression, as biomarkers and therapeutic targets for tumors, it has been widely studied and applied. However, lncRNA in atherosclerosis is still in early stage. This article reviews the research progress of lncRNA in the pathogenesis of AS, in order to provide new ideas for prevention and treatment of AS.
Key words :
Atherosclerosis
Long non-coding RNA
Lesions
Research progress
基金资助: 国家自然科学基金资助项目(81160437);
广西自然科学基金项目(2013GXNSFAA019200)。
通讯作者:
王庆高(1971.3-),男,博士,主任医师;研究方向:中医药防治心血管疾病研究。
作者简介 : 李丽娟(1991.10-),女,广西中医药大学2016级中医内科学专业在读硕士研究生;研究方向:中医药防治心血管疾病研究。
[1] Chen LL,Carmichael GG. Decoding the function of nuclear long noncoding RNAs [J]. Curr Opin Cell Biol,2010,22(3):357-364.
[2] Michalik KM,You X,Manavski Y,et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth [J]. Circ Res,2014,114(9):1389-1397.
[3] Peng Y,Meng K,Jiang L,et al. Thymic stromal lymphopoietin-induced HOTAIR activation promotes endothelial cell proliferation and migration in atherosclerosis [J]. Bioscience Reports,2017,37(4):BSR20170351.
[4] Salmena L,Poliseno L,Tay Y,et al. A ceRNA hypothesis:the rosetta stone of a hidden RNA language? [J]. Cell,146(3):353-358.
[5] Lu W,Huang SY,Su L,et al. Long Noncoding RNA LOC-100129973 suppresses apoptosis by targeting miR-4707-5p and miR-4767 in vascular endothelial cells [J]. Scientific Reports,2016,6:21620.
[6] Zhang BY,Jin Z,Zhao Z. Long intergenic noncoding RNA 00305 sponges miR-136 to regulate the hypoxia induced apoptosis of vascular endothelial cells [J]. Biomed Pharmacother,2017,94:238-243.
[7] Zhang Y,Liu X,Bai X,et al. Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis [J]. J Pineal Res,2018,64(2). doi:10.1111/jpi.12449.
[8] Wu Z,He Y,Li D,et al. Long noncoding RNA MEG3 suppressed endothelial cell proliferation and migration through regulating miR-21 [J]. Am J Transl Res,2017,9(7):3326-3335.
[9] Song TF,Huang LW,Yuan Y,et al. LncRNA MALAT1 regulates smooth muscle cell phenotype switch via activation of autophagy [J]. Oncotarget,2018,9(4):4411-4426.
[10] Pasmant E,Sabbagh A,Vidaud M,et al. ANRIL,a long,noncoding RNA is an unexpected major hotspot in GWAS [J]. FASEB J,2011,25(2):444-448.
[11] Motterle A,Pu X,Wood H,et al. Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells [J]. Hum Mol Genet,2012,21(18):4021-4029.
[12] Congrains A,Kamide K,Oguro R,et al. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B [J]. Atherosclerosis,2012,220(2):449-455.
[13] Ballantyne MD,Pinel K,Dakin R,et al. Smooth Muscle Enriched Long Noncoding RNA(SMILR)Regulates Cell Proliferation [J]. Circulation,2016,133(21):2050-2065.
[14] Li H,Liu X,Zhang L,et al. LncRNA BANCR facilitates vascular smooth muscle cell proliferation and migration through JNK pathway [J]. Oncotarget,2017,8(70):114568-114575.
[15] Sun L,Goff LA,Trapnell C,et al. Long noncoding RNAs regulate adipogensis [J]. Proc Natl Acad Sci USA,2013, 110(9):3387-3392.
[16] Hu YW,Yang JY,Ma X,et al. A lincRNA-DYNLRB2-2/GPR119/GLP-1R/ABCA1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis [J]. J Lipid Res,2014,55(4):681-697.
[17] Huang C,Hu YW,Zhao JJ,et al. Long noncoding RNA HOXC-AS1 suppresses Ox-LDL-induced cholesterol accumulation through promoting HOXC6 expression in THP-1 macrophages [J]. DNA Cell Biol,2016,35(11):722-729.
[18] Han Y,Ma J,Wang J,et al. Silencing of H19 inhibits the adipogenesis and inflammation response in ox-LDL-treated Raw264.7 cells by up-regulating miR-130b [J]. Molecular Immunology,2017,93:107-114.
[19] Molina E,Chew GS,Myers SA,et al. A novel Y-specific long non-coding RNA associated with cellular lipid accumulation in HepG2 cells and atherosclerosis-related genes [J]. Scientific Reports,2017,7(1):16710.
[20] Li D,Cheng M,Niu Y,et al. Identification of a novel human long non-coding RNA that regulates hepatic lipid metabolism by inhibiting SREBP-1c [J]. Int J Biol Sci,2017,13(3):349-357.
[21] Chi JS,Li JZ,Jia JJ,et al. Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis [J]. J Huazhong Univ Sci Technolog Med Sci,2017,37(6):816-822.
[22] Lin Z,Ge J,Wang Z,et al. Let-7e modulates the inflammatory response in vascular endothelial cells through ceRNA crosstalk [J]. Scientific Reports,2017,7:42498.
[23] Zhang DD,Wang WT,Xiong J,et al. Long noncoding RNA LINC00305 promotes inflammation by activating the AHRR-NF-κB pathway in human monocytes [J]. Scientific Reports,2017,7:46204.
[24] Mei Y,Thompson MD,Cohen RA,et al. Autophagy and oxidative stress in cardiovascular diseases [J]. Biochim Biophys Acta,2015,1852(2):243-251.
[25] Torisu K,Singh KK,Torisu T,et al. Intact endothelial autophagy is required to maintain vascular lipid homeostasis [J]. Aging Cell,2016,15(1):187-191.
[26] De Meyer GR,Grootaert MO,Michiels CF,et al. Autophagy in vascular disease [J]. Circ Res,2015,116(3):468-479.
[27] Wang T,Zhang L,Hu J,et al. Mst1 participates in the atherosclerosis progression through macrophage autophagy inhibition and macrophage apoptosis enhancement [J]. J Mol Cell Cardiol,2016,98:108-116.
[28] Ge D,Han L,Huang S,et al. Identification of a novel MTOR activator and discovery of a competing endogenous RNA regulating autophagy in vascular endothelial cells [J]. Autophagy,2014,10:957-971.
[29] Huang S,Lu W,Ge D,et al. A new microRNA signal pathway regulated by long noncoding RNA TGFB2-OT1 in autophagy and inflammation of vascular endothelial cells [J]. Autophagy,2015,11:2172-2183.
[30] Pawar K,Hanisch C,Palma Vera SE,et al. Down regulated lncRNA MEG3 eliminates mycobacteria in macrophages via autophagy [J]. Sci Rep,2016,6:19416.
[31] Li Z,Li J,Tang N. Long noncoding RNA Malat1 is a potent autophagy inducer protecting brain microvascular endothelial cells against oxygen-glucose deprivation/reoxygenation-induced injury by sponging miR-26b and upregulating ULK2 expression [J]. Neuroscience,2017, 354:1-10.
[32] Ma Y,Wang P,Xue Y,et al. PVT1 affects growth of glioma microvascular endothelial cells by negatively regulating miR-186 [J]. Tumour Biol,2017,39(3):1010428317694 326.
[33] Mouse Genome Sequencing Consortium,Waterston RH,Lindblad-Toh K,et al. Initial sequencing and comparative analysis of the mouse genome [J]. Nature,2002,420(6915):520-562.
[34] Chen L,Yang W,Guo Y,et al. Exosomal lncRNA GAS5 regulates the apoptosis of macrophages and vascular endothelial cells in atherosclerosis [J]. PLoS One,2017,12(9):e0185406.
[1]
邢晨1 赵玲2 黄少芳2 李锦锦1. 基于中医传承辅助平台的赵玲教授治疗糖尿病周围神经病变用药规律分析 [J]. 中国医药导报, 2018, 15(9): 109-113.
[2]
黄丽华1 王艳华2 郭建强3. 心力衰竭超声指数对心脏瓣膜病变患者的整体心功能评价的价值分析 [J]. 中国医药导报, 2018, 15(8): 44-47.
[3]
苏晓琳1 王江威1 赵婉1 杨炳友1 匡海学1 王秋红1,2. 独活寄生汤治疗膝骨性关节炎作用机制的现代药理学研究进展 [J]. 中国医药导报, 2018, 15(7): 36-39.
[4]
罗远国 覃万安 吴家昌 林舟丹 杨华. 复合组织瓣修复静脉功能障碍患者组织缺损的研究进展 [J]. 中国医药导报, 2018, 15(7): 44-46,59.
[5]
卢绮韵1 陈本坚2 林玉平2. 糖痹外洗方治疗2型糖尿病周围血管病变患者的效果 [J]. 中国医药导报, 2018, 15(7): 111-114.
[6]
张华月 李琦 付晓伶. 结直肠相关癌前病变动物模型的研究进展 [J]. 中国医药导报, 2018, 15(5): 27-31,36.
[7]
黄蕊 黄永 刘兴钊 何玲. 血清ox-LDL、AIP水平与急性脑梗死患者颈动脉内膜中层厚度的关系 [J]. 中国医药导报, 2018, 15(4): 61-64.
[8]
刘文辉1 肖坚2 孙维华3 杨娜3 刘伯轩3 龚建平3. miR-1203和HOTAIR rs7958904位点对乳腺癌细胞生长的影响 [J]. 中国医药导报, 2018, 15(3): 8-12.
[9]
栗艳萍1 刘声2 . 血脂康胶囊联合缬沙坦对高血压视网膜病变硬化期的短期效果 [J]. 中国医药导报, 2018, 15(3): 107-109,133.
[10]
刘畅 王英南 王旭泽 林红 高宇▲. 老年2型糖尿病患者下肢血管病变的危险因素分析 [J]. 中国医药导报, 2018, 15(24): 51-54.
[11]
方玲1 张琪2 魏恩韬1 贾紫珮1. 基于PI3K/Akt信号通路的中医药改善胰岛素抵抗的研究进展 [J]. 中国医药导报, 2018, 15(23): 26-29.
[12]
黄超楠 黄世敬. 中老年缺血性脑白质病变危险因素的研究进展 [J]. 中国医药导报, 2018, 15(23): 30-33.
[13]
高逸之1 董成林1 左权2 钱紫娟3 李婉青1 张慧1 田晓利1 李仁杰1. 叶酸、VitB12对老年高同型半胱氨酸血症脑梗死伴颈动脉粥样硬化患者Cys C、Hcy、SOD表达的影响 [J]. 中国医药导报, 2018, 15(23): 88-91,95.
[14]
罗伟1 朱志超1 徐宝宏1▲ 罗振华2. 唾液幽门螺杆菌检测在胃癌发生发展中的价值 [J]. 中国医药导报, 2018, 15(22): 88-91.
[15]
程琦1 檀永攀2 宋全1 何玉芳3. 彩色多普勒超声对糖尿病下肢血管病变的评估价值及与血清Lp-PLA2、25(OH)D3水平的关系 [J]. 中国医药导报, 2018, 15(22): 123-126.